AAPharmaSyn had a broad network of strategic alliances designed to solve the most demanding drug development challenges. Our extended team consists of recognized experts in:
1. Pre-Clinical Development
Chemical Synthesis:
Assisting in the development of scalable and reproducible chemical synthesis routes for the active pharmaceutical ingredient (API).
Characterization:
Determining the physical and chemical properties of the API, including solubility, stability, and purity.
Analytical Methods Development:
Developing and validating analytical methods for the identification, quantification, and purity assessment of the API.
2. Formulation Development
Formulation Design:
Designing formulations that ensure the stability, bioavailability, and patient compliance of the drug product. This includes selecting appropriate excipients and dosage forms (e.g., tablets, capsules, solutions).
Preformulation Studies:
Conducting studies to understand the API’s physicochemical properties and their impact on formulation development.
3. Process Development
Scale-Up:
Developing and optimizing manufacturing processes that can be scaled from laboratory to pilot plant and commercial production.
Process Optimization:
Ensuring that the manufacturing process is robust, efficient, and capable of producing consistent product quality.
Technology Transfer:
Facilitating the transfer of manufacturing processes from development to commercial production sites.
4. Analytical Development and Validation
Analytical Method Validation:
Ensuring that analytical methods are suitable for their intended purpose and comply with regulatory requirements.
Stability Studies:
Designing and conducting stability studies to determine the shelf-life of the drug product and to establish storage conditions.
5. Regulatory Strategy and Submissions
Regulatory Documentation:
Preparing and reviewing CMC sections of regulatory submissions, including Investigational New Drug (IND) applications, New Drug Applications (NDA), and Marketing Authorization Applications (MAA).
Compliance:
Ensuring that all CMC activities comply with Good Manufacturing Practices (GMP) and other regulatory guidelines.
Regulatory Interactions:
Acting as a liaison between the company and regulatory authorities, addressing questions and concerns related to CMC aspects of submissions.
6. Quality Control and Assurance
Quality Control Testing:
Establishing and overseeing quality control testing protocols to ensure the product meets all specifications.
Quality Assurance Systems:
Developing and implementing quality assurance systems to monitor and ensure compliance with GMP and regulatory standards.
7. Supply Chain Management
Raw Material Sourcing:
Identifying and qualifying suppliers for raw materials and ensuring their quality and consistency.
Production Planning:
Coordinating production schedules and supply chain logistics to meet project timelines and market demands.
8. Troubleshooting and Problem-Solving
Technical Support:
Providing technical support to resolve manufacturing, formulation, or analytical issues that arise during development or commercial production.
Continuous Improvement:
Identifying opportunities for continuous improvement in manufacturing processes, product quality, and regulatory compliance.
9. Project Management
Timelines and Milestones:
Managing project timelines, setting milestones, and ensuring that all CMC activities are completed on schedule.
Cross-Functional Coordination:
Coordinating with other departments such as clinical development, regulatory affairs, and marketing to ensure alignment and successful project outcomes.
10. Training and Knowledge Transfer
Training Programs:
Developing and delivering training programs for staff on CMC-related topics.
Documentation and Knowledge Sharing:
Ensuring proper documentation of all CMC activities and facilitating knowledge transfer within the organization.
Bringing new therapeutic solutions to the patient requires coordination between multiple stakeholders with a wide range of short-term objectives. This process is underpinned by a skillful and nuanced choreography. It is far too often that the process breaks down due to the lack of team cohesion and nonconstructive abrasion.
We observe that project management is often downplayed as a skill inferior to subject matter expertise. In reality, there is ample evidence to show that poor proactive communication and subpar methodical disciplined execution in the face of impinging “emergencies” are key determinants in the downfall many early-stage drug discovery programs.
AAPharmaSyn personnel goes to great lengths to ensure that our client receive superior consulting services.
